Actinium Pharmaceuticals (ATNM) Return on Capital Employed [ROCE] (2012 - 2026)
Actinium Pharmaceuticals' Return on Capital Employed [ROCE] was 28.49% in Q2 2026, up 105.42 percentage points from -76.93% a year earlier and up 90.33 percentage points from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Return on Capital Employed [ROCE] (2012 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Actinium Pharmaceuticals came in at -64.30%, down 5.00 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for four consecutive years, though with a five-year change of +1.05 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -59.31% in FY2024 (-1.18 pp), -58.13% in FY2023 (-18.77 pp), -39.35% in FY2022 (-1.84 pp) and -37.51% in FY2021 (+27.84 pp).
- The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2012.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in four of the last eight quarters, with an average year-over-year change of +8.82 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2026 (a gain of 105.42 percentage points); the worst was Q4 2023 (a drop of 35.17 percentage points).
- Per Business Quant data, ATNM's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -61.84% (Q1 2026), -78.81% (Q4 2025) and -70.78% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Actinium Pharmaceuticals | 49.05 Mn | -130.95 Mn | - | 28.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.49% |
| Mar 31, 2026 | -61.84% |
| Dec 31, 2025 | -78.81% |
| Sep 30, 2025 | -70.78% |
| Jun 30, 2025 | -76.93% |
| Mar 31, 2025 | -74.87% |
| Dec 31, 2024 | -59.03% |
| Sep 30, 2024 | -57.47% |
| Jun 30, 2024 | -58.84% |
| Mar 31, 2024 | -64.99% |
| Dec 31, 2023 | -67.69% |
| Sep 30, 2023 | -61.96% |
| Jun 30, 2023 | -52.87% |
| Mar 31, 2023 | -40.42% |
| Dec 31, 2022 | -32.52% |
| Sep 30, 2022 | -27.81% |
| Jun 30, 2022 | -29.96% |
| Mar 31, 2022 | -34.50% |
| Dec 31, 2021 | -33.02% |
| Sep 30, 2021 | -29.09% |
API Access
Actinium Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();